Taro

JUL 13, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Lamotrigine (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval action for lamotrigine orally disintegrating tablet labeling; does not report clinical trial data or efficacy evidence.